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a  b  s  t  r  a  c  t
Inside  the  human  body,  reactive  derivatives  of oxygen,  known  as reactive  oxygen  species
(ROS) such  as the  superoxide  radical  (O2•),  hydroxyl  radical  (•OH)  and  hydrogen  perox-
ide (H2O2),  are  constantly  generated.  The  ROS  easily  cause  oxidative  damage  to various
biomolecules  such  as  proteins,  lipids  and  DNA  leading  to various  disease  conditions.  Iron
chelators function  as antioxidants  by scavenging  ROS  and  also  reduce  the amount  of  avail-
able iron  thereby  decreasing  the  quantity  of •OH  generated  by  Fenton  reactions.  In  this
study,  the  antioxidant  activity  of the  iron  chelators:  caffeic  acid  (CA),  2,3-dihydroxybenzoic
acid  (DHBA),  desferroxamine  B (FOB)  and  benzohydroxamic  acid  (BHA)  were  determined
using ﬁve  different  in  vitro  antioxidant  assays.  The  antioxidant  assays  used  were:  iron
binding  ability,  reducing  ability  using  the potassium  ferricyanide  reduction  method,  1,1-
diphenyl-2-picrylhydrazyl  (DPPH)  radical  scavenging  activity,  H2O2 scavenging  activity
and •OH  scavenging  activity.  The  standard  used  for the  iron  binding  ability  was  Na2EDTA
whereas  vitamin  C  was  used  as  a standard  for the  remaining  assays.  The  iron  chelators
showed  a concentration  dependent  increase  in  their radical  scavenging  activities  as  well
as their  reducing  ability.  At  the concentration  of  1 mM,  FOB  had  the  highest  iron  binding
ability  of  93.7%  whereas  DHBA  had  the  lowest  iron  binding  ability  of  5.0%  compared  to the
standard  Na2EDTA  which  had  94.8%. The  iron  chelators,  with  the  exception  of  BHA,  showed
good  reducing  ability  than  vitamin  C. Caffeic  acid  showed  signiﬁcant  DPPH,  hydrogen  per-
oxide and  hydroxyl  radical  scavenging  activities  of  84.7%,  99.8%  and  14.5%,  respectively.  All
the iron  chelators  were  observed  to show  signiﬁcant  activities  in  all ﬁve  antioxidant  assays.
©  2015  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
Y-NC-Nthe  CC  B
. Introduction
The role of free radicals in many disease conditions has
een well established. Inside the human body, reactive
erivatives of oxygen, known as reactive oxygen species
ROS) such as the superoxide radical (O2•), hydroxyl
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radical (•OH) and hydrogen peroxide (H2O2), are con-
stantly generated from contact with foreign chemicals
in our ambient environment and/or due to a number of
local metabolic processes that utilizes redox enzymes [1].
Normally, the ROS generated in humans are cleared by the
presence of antioxidants in the body and there is a balance
between the ROS generated and the antioxidants present.
However, owing to ROS overproduction or inadequate
antioxidant defense, this balance is disturbed favouring the
ROS increase that end up in oxidative stress [1]. Apart from
their deleterious effect, free radicals have been implicated
 access article under the CC BY-NC-ND license (http://creativecommons.
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in a number of biological processes which include intracel-
lular killing of bacteria by phagocytes such as macrophages
and granulocytes and these are necessary for life. Free
radicals have also been associated with a number of cell
signalling processes called redox signalling [2].
Although the body has effective defense mechanisms
that protect it against oxidative stress, the ability of these
defensive mechanisms decreases as one ages [3], creating a
need to provide the body with a constant supply of antiox-
idants through dietary supplements. Several biomolecules
such as proteins, lipoproteins, lipids and DNA are easily
damaged due to the actions of ROS [4]. Epidemiological
studies have found that the intake of antioxidants, such
as vitamin C, reduce the risk of cardiovascular diseases,
cancers [5] and neurodegenerative diseases [6].
Many radical reactions can be formed from ferrous
iron (Fe2+) by virtue of its ability to transfer single elec-
trons, starting even with relatively non-reactive radicals
[7]. Hence, iron chelation may  be an effective therapeu-
tic approach. However, due to absence of effective ligands,
advancement in this ﬁeld has been hindered. Also, there is
the need for a balance between the toxic effects of chelators
and their relative favourable effects against oxidative dam-
age. Red blood cells have been found to be protected from
oxidative injury by antioxidant and other supportive ther-
apies [8,9]. Iron chelators are involved in mobilizing iron
from tissues by forming soluble, stable complexes that are
then passed out through faeces or urine. Iron-related com-
plications are reduced by chelation therapy and by so doing
improves quality of life and overall persistence [10]. Avail-
able chelators are deemed suboptimal due to their poor
oral bioavailability, short plasma half-life and serious side
effects [10]. Within this background and taking particular
attention to the relative paucity of iron chelating agents,
it is not storming that clinical scientists are laying much
emphasis towards discovering potentially useful sources of
iron chelators in order to acquire the maximum potential
beneﬁt with the least possible harm [11,12].
In this study, the antioxidant and free radical scavenging
activities of the iron chelators: caffeic acid (CA), 2,3-
dihydroxybenzoic acid (DHBA), desferroxamine B (FOB)
and benzohydroxamic acid (BHA) (Fig. 1.1) were evalu-
ated using in vitro assays including: iron binding ability;
Fig. 1.1. Structures of iron chelators used in this study.Reports 2 (2015) 721–728
reducing ability using the potassium ferricyanide reduction
method; 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical
scavenging activity; H2O2 scavenging activity and •OH
scavenging activity.
2. Materials and methods
2.1. Materials
Methanol was  obtained from BDH chemicals limited,
Poole-England. Caffeic acid (CA) and 2,3-dihydroxybenzoic
acid (DHBA) were obtained from Sigma, Switzerland. Des-
ferroxamine B (FOB) was obtained from Ciba-Geigy Ltd.
(now Norvatis), Switzerland. Benzohydroxamic acid (BHA)
was  obtained from Sigma, United Kingdom. Butylated
Hydroxy toluene (BHT), Ferrozine and DPPH were obtained
from Sigma-Aldrich Inc., UK.
2.2. Preparation of solutions
2.2.1. Preparation of stock solutions
The stock solutions of each of the iron chelators (FOB,
BHA, DHBA and CA) were prepared by dissolving a weighed
amount of each chelator in a total volume of 10 ml
methanol to give 10 mM concentration. Stock solutions of
EDTA (10 mM),  and vitamin C (10 mM)  were also prepared
and used as positive standards.
2.2.2. Preparation of working solutions of iron chelators
Working solutions of 1 mM and 2 mM concentrations
were prepared from the 10 mM stock solutions of the iron
chelators for each assay. All other reagents used were
prepared by accurate dilutions from stock solutions. Reac-
tions were carried out in duplicate. The choice of the two
working concentrations was based on a data published by
Gulcin in 2006 where caffeic acid was  used in a concentra-
tion range of 10–20 g/ml which translates into a molar
concentration range of approximately 0.05–0.1 mM.  We
decided to carry out our study at 1–2 mM concentrations
of the chelators to investigate their effect at a much higher
concentration.
2.3. Determination of iron binding ability of chelators
Iron (II) binding ability of the chelators was  determined
according to the method of Dinis et al. [13] except that
ferrous sulphate was  substituted for ferrous chloride. Fer-
rozine can quantitatively form complexes with ferrous iron
yielding a red colour. However, in the presence of chelating
agents, there is disruption of the formation of the complex
which leads to a decrease in the red colour. Measurement of
colour reduction gives an estimation of the binding ability
of the coexisting chelator.
The ferrous ion was  monitored by measuring the forma-
tion of a red ferrous ion-ferrozine complex at 562 nm. The
iron chelators (940 l) at working concentrations of 1 mM
and 2 mM were each mixed with 20 l of ferrous sulphate
(2 mM)  and ferrozine added to a concentration of 0.2 mM to
start the reaction. The resulting mixture was mixed thor-
oughly and left to stand for 10 min  at room temperature.
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he higher the absorbance at 562 nm (which is due to the
errous ion-ferrozine complex), the weaker the ferrous iron
inding strength of the chelator. Percentage inhibition was




here Ao is the absorbance of the control, and As is the
bsorbance of the iron chelator.
.4. Determination of reducing ability of iron chelators
The reducing ability of the iron chelators was deter-
ined by the method of Oyaizu [14] with a slight
odiﬁcation. The reducing ability assay is based on the
rinciple that substances, which have reduction poten-
ial, react with potassium ferricyanide (K3Fe3+(CN)6) to
orm potassium ferrocyanide (K4Fe2+(CN)6) (2), which then
eacts with ferric chloride to form a ferric-ferrous complex
3) that has an absorption maximum at 700 nm.
3Fe3+(CN)6(aq) + Ironchelator[red](aq) → K4Fe2+(CN)6(aq)
+ Ironchelator[ox](aq) (2)
4Fe2+(CN)6(aq) + FeCl3(aq) → KFe3+Fe2+(CN)6(aq)
+ 3KCl(aq) (3)
An aliquot (2.5 ml)  of each chelator at 1 mM and 2 mM
oncentration was added to test tubes containing 2.5 ml
f phosphate buffer (200 mM,  pH 6.6) and 2.5 ml  of 1%
otassium ferricyanide [K3Fe(CN)6]. The mixtures were
ncubated in a water bath at 50 ◦C for 20 min  and cooled
apidly on ice. They were then mixed with 2.5 ml  of 10%
richloroacetic acid (TCA) to stop the reaction. The mix-
ures were centrifuged at 1000 × g for 10 min  and 5 ml  of
istilled water added to 5 ml  of the supernatant. Ferric chlo-
ide was then added to a concentration of 0.1%. The mixture
as mixed and allowed to stand for 10 min  at room tem-
erature after which the absorbance was taken at 700 nm.
n absorbance at 700 nm,  which is due to the formation of
 Perl’s Prussian blue potassium ferrocyanide-ferric com-
lex, is a measure of the reducing ability of the chelator.
ncreasing absorbance at 700 nm indicates an increase in
eductive ability.
.5. Determination of free radical scavenging activity of
ron chelators
.5.1. DPPH free radical scavenging activity
The DPPH radical scavenging method is widely used
o evaluate the free radical scavenging ability of natural
ntioxidants [15]. DPPH is a stable nitrogen-based free
adical which has a violet colour that changes to yel-
ow after reduction by either the process of hydrogen- or
lectron-transfer. Substances which are able to execute
his reaction can be considered as antioxidants and there-
ore radical scavengers [16]. In the radical form, the DPPH
olecule has an absorbance at 517 nm which disappears
fter acceptance of an electron or hydrogen radical fromReports 2 (2015) 721–728 723
an antioxidant compound to become a stable diamagnetic
molecule [17].
The free radical scavenging activities of the chelators
were estimated using DPPH according to the method of
Yokozawa et al. [18]. To 1 ml  methanolic solution of DPPH
(0.08 mM)  in Eppendorf tubes, 300 l of the iron chelators
were added. The resultant mixture was  shaken thoroughly
and allowed to stand at room temperature in the dark
for 30 min  after which the absorbance of the solution was
measured at 517 nm.  Vitamin C was used as the positive
standard and methanol as the blank. The negative control
contained DPPH and methanol but no iron chelator. The
ability to scavenge DPPH radical was  calculated using the
formula in Eq. (4);
Scavenging activity (%)
= Absorbance of control − Absorbance of test sample
Absorbance of control
× 100 (4)
2.5.2. H2O2 radical scavenging activity
The ability of the iron chelators to scavenge H2O2 was
determined according to the method of Ruch et al. [15].
A solution of hydrogen peroxide (40 mM)  was prepared
in phosphate buffer (pH 7.4). The concentration of hydro-
gen peroxide was determined by absorption at 230 nm
using a spectrophotometer. The iron chelators (500 l each
at 1 mM)  were added to 1 ml of the hydrogen peroxide
solution (40 mM).  The absorbance of hydrogen peroxide at
230 nm was read after ten minutes against a blank solu-
tion of phosphate buffer not having hydrogen peroxide. The
percentage of hydrogen peroxide scavenged by the iron
chelators and standard compound were calculated using
formula in Eq. (2). The procedure was  repeated for the iron
chelators at 2 mM concentrations but with 3% hydrogen
peroxide solution.
2.5.3. •OH radical scavenging activity
Hydroxyl radicals generated by the Fenton reac-
tion (Fe3+-ascorbate-EDTA-H2O2 system) were measured
according to the method of Chung et al. [19] with a slight
modiﬁcation. Hydrogen peroxide is able to undergo a set
of reaction known as the Fenton reaction to release the
hydroxyl radical in the presence of iron. Hydroxyl radical
scavenging activity is based on the quantiﬁcation of the
2-deoxyribose degradation product, malonaldehyde, by its
condensation with thiobarbituric acid (TBA) to give a yel-
low colour which absorbs at 532 nm.
The Fenton reaction mixture consisted of 0.2 ml
FeSO4·7H2O (10 mM),  0.2 ml  EDTA (10 mM)  and 0.2 ml  2-
deoxyribose (10 mM)  mixed with 1.2 ml  phosphate buffer
(0.1 M,  pH 7.4). The iron chelators (0.2 ml  at 1 mM and
2 mM)  were added to the Fenton reaction mixture followed
by 0.2 ml  H2O2 (10 mM)  and incubated at 37 ◦C for 4 h. Fol-
lowing incubation, 1 ml  TCA (2.8%) and 1 ml  TBA (1%) were
added to the reaction mixture and placed in a boiling water
bath for 10 min  for colour development. The resultant mix-
ture was  brought to room temperature and centrifuged at
1000 × g for 3 min  and the absorbance measured at 532 nm
against a blank solution. Vitamin C was used as a positive
icology 724 J.P. Adjimani, P. Asare / Tox
control. Radical scavenging activity was calculated using
Eq. (2).
3. Results and discussion
Reactive oxygen species cause damage to cellular
biomolecules such as proteins, nucleic acids, lipids and car-
bohydrates [4]. Antioxidants interfere with the generation
of ROS and also play a crucial role in their inactivation.
Although, human cells protect themselves against oxida-
tive damage by antioxidants, these are occasionally not
sufﬁcient to prevent ROS induced cellular damage [3].
The study investigated antioxidant and free radical
scavenging potential of iron chelators based on their abil-
ity to (i) chelate metal ions, (ii) reduce ferric to ferrous ion,
(iii) scavenge non biological stable free radical (DPPH) and
(iv) scavenge biologically important oxidants such as H2O2
and •OH. Iron chelators were tested for antioxidant activ-
ity in four different in vitro assays namely, reducing ability
(Fig. 3.2), DPPH radical scavenging activity (Fig. 3.3), H2O2
scavenging activity (Fig. 3.4) and •OH radical scavenging
activity (Fig. 3.5). The ferrous ion binding ability of the iron
chelators was also determined (Fig. 3.1). The iron chelators
did not only exhibit iron binding ability but also free radical
scavenging activity. It was found that the radical scaveng-
ing activities as well as the reducing ability of all the iron
chelators generally increased with an increase in chelator
concentration [20].
3.1. Iron binding ability of chelators
The chelation of Fe2+ was estimated by the method of
Dinis et al. [13].
Desferroxamine B and benzohydroxamic acid had high
iron binding abilities of 93.7% and 61.5%, respectively as
compared to the standard Na2EDTA which had a chelat-
ing activity of 94.8%. Caffeic acid and DHBA had relatively
low iron binding abilities of 24.4% and 5.0% respectively
(Fig. 3.1).
The iron binding ability of the chelators could be related
to the type of functional group used in iron chelation. The
hydroxamate chelators (FOB and BHA) showed high iron
binding ability whereas the catecholate chelators (CA and
DHBA) showed low iron binding ability. The free radical
scavenging activities of the chelators showed a different
trend (Figs. 3.3–3.5). Desferroxamine B had the highest iron
binding ability and this could be due to the three biden-
tate ligand structure within the molecule. Roosenberg et al.
[21] have demonstrated that the siderophores that have
three bidentate ligands inside their structure are the most
effective and by virtue of that are able to form hexaden-
tate complexes with smaller entropic variations than that
caused by chelating one ferric ion with separate ligands.
3.2. Total reductive capability
A signiﬁcant indicator of the antioxidant potency of a
compound is its reducing ability. Benzohydroxamic acid
showed the least reducing ability of 0.394 whereas CA,
DHBA and FOB showed higher reducing abilities of 1.736,
1.697 and 1.442 respectively as compared to the vitamin CReports 2 (2015) 721–728
standard which gave a reducing ability of 1.114 (Fig. 3.2).
All the chelators showed concentration dependent reduc-
ing ability, indicating that the chelators were capable of
donating hydrogen atoms. All the iron chelators are capa-
ble of donating 3 hydrogen atoms per molecule with the
exception of BHA which can only donate 1 hydrogen atom
per molecule. The ability of BHA to donate only 1 hydrogen
atom per molecule might be the reason why  it showed a
lower reducing ability as compared to the remaining chela-
tors. Previous studies have correlated the reducing capacity
of phytocompounds to their electron-donating ability [22].
Hence it can be stated that the effective electron (hydro-
gen) donating ability of the chelators contributed to the
observed overall antioxidant property.
3.3. DPPH free radical scavenging activity
In the DPPH assay, the iron chelators were able to reduce
the stable DPPH radical to the yellow coloured diphenyl-
picrylhydrazine indicating their abilities to scavenge DPPH
radical. Benzohydroxamic acid had the least DPPH radical
scavenging activity of 45.0% whereas DHBA had the high-
est activity of 84.9%. Caffeic acid had an activity of 84.7% at
[1 mM]  and vitamin C had an activity of 84.3% (Fig. 3.3). The
iron chelators, on interacting with DPPH, might have trans-
ferred an electron to it, thus neutralizing its free radical
nature as observed by Oyaizu [14].
3.4. Hydrogen peroxide scavenging activity
The highest percentage H2O2 radical scavenging activity
of 99.8% was obtained with CA followed by BHA which had
99.2% scavenging activity. Desferroxamine B and DHBA had
50.1% and 91.1% H2O2 scavenging activities respectively.
Vitamin C had H2O2 scavenging activity of 51.76%. There
were no differences in the free radical scavenging activi-
ties of the iron chelators at 1 mM and 2 mM concentration
(Fig. 3.4).
Hydrogen peroxide can accept protons (H+) or electrons
and by so doing be reduced to H2O. In a H2O2 scavenging
activity, the iron chelators act as hydrogen peroxide scav-
engers by donating hydrogen atoms to reduce the hydrogen
peroxide to H2O [23].
3.5. Hydroxyl radical scavenging activity
For the •OH radical scavenging assay, BHA gave a
low scavenging activity of 9.0% compared to the stan-
dard vitamin C which gave a scavenging activity of
12.2%. CA, DHBA and FOB gave higher activities. The •OH
scavenging activities of the iron chelators were in the fol-
lowing decreasing order: CA (14.5%) > DHBA (13.4%) > FOB
(13.3%) > BHA (9.0%) (Fig. 3.5). This trend could be probably
due to their hydrogen atom donating ability.
One of the natural phenolic compounds which is broadly
distributed in plant materials such as fruits, vegetables and
tea is caffeic acid [24]. As an antioxidant it can scavenge
a number of reactive species, including DPPH [20], per-
oxyl and hydroxyl radicals [25]. Caffeic acid has a variety of
potential pharmacological activities which could be due to
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Fig. 3.1. Iron binding ability of chelators. Solutions of iron chelators and Na2EDTA were prepared at 1 mM and 2 mM concentrations and 940 l aliquot of
each  solution was  used for the iron binding ability in a total volume of 1 ml  reaction mixture. Each value is the average of two experiments with error bars
indicating standard error of mean (SEM). Na2EDTA was used as a positive control.
Fig. 3.2. Reducing ability of iron chelators. Solutions of iron chelators and vitamin C at 1 mM and 2 mM concentrations were prepared and 2.5 ml aliquot of
each  solution was  used for the reducing ability assay in a total volume of 7.5 ml  reaction mixture. Each value is the average of two  experiments with error
bars  indicating SEM. Vitamin C was used as a positive control.
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Fig. 3.3. DPPH radical scavenging activity of iron chelators. Solutions of iron chelators and vitamin C at 1 mM and 2 mM concentrations were prepared and
300  L aliquot of each solution was used for the DPPH scavenging activity in a total volume of 1.3 ml  reaction mixture. Each value is the average of two
experiments with error bars indicating SEM. Vitamin C was used as a positive control.
Fig. 3.4. Hydrogen peroxide scavenging activity of iron chelators. (a) and (b) represents H2O2 scavenging activity for the iron chelators at 1 mM and
2  mM concentrations respectively. Solutions of iron chelators and vitamin C at 1 mM and 2 mM concentrations were prepared and 500 L aliquots of each
solution was  used for the H2O2 scavenging activity in a total volume of 1.5 ml  reaction mixture. Each bar represents the mean ± SEM; all determinations
were  performed in duplicate. Vitamin C was  used as a positive control.
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[ig. 3.5. Hydroxyl radical scavenging activity of iron chelators. Solutions
liquots of each solution was used for the •OH scavenging activity in a tota
ith error bars indicating SEM. Vitamin C was used as a positive control.
ts high free radical scavenging activity as observed in this
tudy.
.6. Limitations of study
While this study appears to highlight the outstanding
ntioxidant properties of caffeic acid, the study is limited
o deductions based only on the molar concentrations of
 mM and 2 mM for the chelators used. The observations
ade in the study may  or may  not be the same if a wider
oncentration range was used.
. Conclusion
It can be concluded from the study that all the iron
helators have antioxidant and free radical scavenging
ctivities. Caffeic acid had the highest free radical scav-
nging activity. This study makes valuable addition to the
xisting wealth of information on this indigenous natural
ntioxidant. Further studies would be needed to demon-
trate the mechanism of the observed actions.
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